Hyaluronidase is not optional equipment for a filler clinic. It is the safety net that every aesthetic practitioner administering hyaluronic acid fillers must have immediately to hand and the quality, concentration, and reliability of your chosen formulation matters clinically. This guide covers everything you need to know about Innoaesthetics Hyaluronidase 4×500 IU: what it does, when to use it, how to dose it, and why the freeze-dried 500 IU format is the practitioner's choice for 2026.
PRODUCT QUICK FACTS — INNOAESTHETICS HYALURONIDASE 4×500 IU
- Active ingredient: Hyaluronidase 500 IU per vial
- Pack size: 4 vials (2,000 IU total)
- Presentation: 5ml bottle, 1ml freeze-dried (lyophilised) product per vial
- Manufacturer: Innoaesthetics, Spain
- Reconstitution: Sterile saline (1ml per vial), use immediately
- Indications: Over-correction, asymmetry, Tyndall effect, vascular occlusion, oedema, fibrosis
- Application: Injectable (intradermal / subcutaneous) and topical
-
For use by: Qualified aesthetic practitioners only
What Is Hyaluronidase and Why Does Every Filler Clinic Need It?
Hyaluronidase is a naturally occurring enzyme found in the human body. Its role is to break down hyaluronic acid (HA) — the same molecule that forms the basis of the vast majority of dermal fillers used in aesthetic medicine today, including Juvederm, Restylane, Teosyal, and Belotero.
When hyaluronidase is injected adjacent to or directly into an HA filler deposit, it hydrolyses the molecular bonds within the HA chains — dissolving the gel matrix. The fragments are then cleared by the body's lymphatic system, typically within hours to a few days depending on the volume being dissolved and the degree of filler cross-linking.
The clinical significance of this is profound. Hyaluronidase transforms HA fillers from permanent-risk procedures into reversible, correctable treatments. It is what allows practitioners to say with confidence to their clients: if you don't love the result, we can adjust it.
99% of experienced aesthetic practitioners in a major survey stocked hyaluronidase on-site not just for corrections, but as emergency safety protocol for vascular events.
Despite this near-universal consensus on the importance of having hyaluronidase available, there remains significant variability in how practitioners store it, prepare it, and dose it. Choosing a high-quality, precisely dosed formulation like Innoaesthetics Hyaluronidase 500 IU — removes one major variable from that equation.
⚠ Clinical Safety Requirement: The JCCP, Save Face, and leading UK aesthetic training bodies are unambiguous: hyaluronidase must be immediately available at every HA filler treatment session. This is not a recommendation — it is a patient safety standard. Any practitioner administering HA filler without hyaluronidase on-site is operating below the accepted standard of care.
What Practitioners Are Searching For And What the Research Says
Based on current search data and clinical literature from 2025–2026, the questions aesthetic practitioners and their clients are asking most frequently about hyaluronidase fall into six categories. This guide addresses every one of them.
|
Search Category |
Top Questions Being Asked |
|
Product sourcing |
"Buy hyaluronidase UK" / "innoaesthetics hyaluronidase supplier" / "hyaluronidase 500 IU UK" |
|
Dosing & protocol |
"How many units of hyaluronidase to dissolve filler?" / "hyaluronidase dosing protocol 2026" |
|
Mechanism |
"How does hyaluronidase work?" / "Does hyaluronidase dissolve natural HA?" |
|
Filler type comparison |
"Does hyaluronidase work on Juvederm?" / "Monophasic vs biphasic filler dissolution" |
|
Safety & side effects |
"Is hyaluronidase safe?" / "Hyaluronidase allergy risk" / "Post-hyaluronidase syndrome" |
|
Emergency use |
"Hyaluronidase vascular occlusion dose" / "Filler emergency protocol UK" |
How Does Hyaluronidase Actually Work? The 2026 Clinical Picture
The mechanism is well understood: hyaluronidase is a glycoside hydrolase enzyme that cleaves the 1,4-glucuronidic bonds in hyaluronic acid chains. This breaks apart the cross-linked HA gel structure, reducing its viscosity and cohesivity until the filler loses its volumising properties and is metabolised by the body.
What is increasingly appreciated in 2026 following research published in the Journal of Cosmetic Dermatology and Plastic and Reconstructive Surgery Global Open is that the mechanism is more nuanced than simply "dissolving" filler. Leading researchers now prefer the term "filler modification" rather than "filler dissolution," because:
- Hyaluronidase primarily acts on the surface of filler particles, gradually breaking them down rather than penetrating deeply into the filler mass
- Clinically meaningful improvement frequently coexists with residual HA detectable on ultrasound or MRI
- Highly cross-linked (monophasic) fillers require higher concentrations and longer treatment times than biphasic fillers, which dissolve more readily at lower concentrations
- Hyaluronidase activity diminishes within approximately 30 minutes in biological tissue — making timely intervention critical in emergency scenarios
BIPHASIC VS. MONOPHASIC FILLER WHAT PRACTITIONERS NEED TO KNOW
Biphasic fillers (e.g. some Restylane products) have looser particle spacing and respond to hyaluronidase rapidly — often within 1–2 hours at standard concentrations.
Monophasic fillers (e.g. some Juvederm products) have denser cross-linking and typically require higher doses, direct injection into the filler mass, and may need multiple sessions for complete dissolution.
Dose your hyaluronidase accordingly the 500 IU per vial concentration of Innoaesthetics allows precise titration across both filler types.
Clinical Indications — When to Reach for Hyaluronidase
1. Vascular Occlusion — Emergency Protocol
This is the most critical indication and the reason hyaluronidase must always be on the treatment room shelf, not locked in a storage room. If HA filler is accidentally injected into or compresses a blood vessel, it can cause vascular occlusion — cutting off blood supply to the skin and potentially causing necrosis, visual disturbance, or, in extremely rare cases, stroke.
Immediate high-dose hyaluronidase injected into the affected area and, for ocular complications, into the perivascular space is the primary emergency intervention. Pharmacokinetic research confirms that hyaluronidase activity diminishes within 30 minutes in tissue, reinforcing the need for immediate action and repeated dosing as required.
Emergency Protocol Reminder: Know your vascular occlusion protocol before you pick up a syringe. Have your hyaluronidase reconstituted and ready to administer. Know the dose. Know who to call. Preparation is not optional.
2. Correcting Over-Correction
Even the most experienced practitioners occasionally achieve more volume than intended — or a client's aesthetic preference changes after treatment. Hyaluronidase provides a controlled, safe pathway to partial or complete dissolution. The staged two-session protocol — treating conservatively, then reassessing one week later — is the clinical standard for achieving precise correction without over-dissolving.
3. Asymmetry Correction
Where filler has settled unevenly, migrated, or was placed asymmetrically, targeted injection to the overfilled side allows correction without requiring full dissolution. Precision is paramount small doses, well placed, achieve more predictable outcomes than aggressive single-session approaches.
4. Tyndall Effect
The Tyndall effect a blue-grey discolouration most commonly seen under the eyes and around the lips occurs when filler is placed too superficially in the skin. Light scatters through the HA gel, creating the distinctive bluish tinge. Hyaluronidase injected into the superficial deposit resolves the discolouration, typically within a few days.
5. Lower Eyelid Oedema (Malar Oedema)
Persistent lower eyelid puffiness following tear trough filler is a well-documented complication, and one of the leading indications for hyaluronidase in the periocular area. A 2024 study reviewing 90 patients found that swelling was the primary indication for hyaluronidase treatment in 52% of cases in the periocular region — underscoring the frequency of this clinical need.
6. Hypertrophic Scars and Skin Fibrosis
Hyaluronidase has applications beyond filler correction. By breaking down the excess glycosaminoglycan matrix that contributes to hypertrophic scarring and fibrosis including post-liposuction and post-surgical fibrosis it can improve tissue pliability and reduce the appearance of abnormal scarring.
7. Topical Application
Innoaesthetics Hyaluronidase is formulated to support topical use. Mixed with two ampoules of saline solution and applied with circular massage, it can address superficial HA deposits or complement injectable correction protocols in appropriate cases.
Stocking hyaluronidase is a patient safety standard, not an upsell. Order Innoaesthetics Hyaluronidase 4×500 IU from Medics World Supply →
Product Specifications — Innoaesthetics Hyaluronidase 4×500 IU
|
SPECIFICATION |
DETAIL |
|
Product name |
Innoaesthetics Hyaluronidase |
|
Also known as |
Hyaluronidase 500 IU / Hyaluronidase 1500 IE (European notation) / Hyaluronidase Innoaesthetics |
|
Pack size |
4 vials × 500 IU = 2,000 IU total |
|
Concentration per vial |
500 IU / 1ml saline (post-reconstitution) |
|
Vial format |
5ml bottle containing 1ml freeze-dried (lyophilised) product |
|
Reconstitution |
Sterile saline solution — use immediately after mixing |
|
Application routes |
Injectable (intradermal / subcutaneous) and topical |
|
Manufacturer |
Innoaesthetics, Spain |
|
Suitable users |
Qualified aesthetic practitioners only |
Why Innoaesthetics? What Makes the 500 IU Freeze-Dried Format Different
Not all hyaluronidase products are clinically equivalent. The formulation, purity, concentration, and stability of the product you stock directly affects your clinical outcomes and your patients' safety. Here is why practitioners are choosing Innoaesthetics Hyaluronidase 4×500 IU:
Precise 500 IU Dosing
The 500 IU concentration allows staged, titratable correction. For delicate areas like the tear trough or lips, starting conservatively and reassessing is the accepted best practice. A 500 IU vial gives you enough product for a meaningful corrective session without over-committing.
Lyophilised (Freeze-Dried) Stability
Enzyme products are inherently sensitive to temperature and time. The freeze-dried format of Innoaesthetics Hyaluronidase dramatically extends shelf stability compared to liquid formulations ensuring that the enzyme retains full potency until the moment of reconstitution. You reconstitute only what you need, immediately before use. A major aesthetic practice survey found that approximately half of respondents stored reconstituted hyaluronidase a practice that risks reduced potency. The lyophilised format removes this risk entirely.
4-Vial Pack = Clinical Readiness
A single vial is not adequate clinical preparation. A vascular occlusion emergency may require multiple vials administered rapidly. A 4-vial pack ensures you are never at risk of running out mid-treatment. One leading US clinic reported maintaining a minimum of 16 vials on site at all times the 4-vial Innoaesthetics pack allows you to maintain a sensible buffer stock.
Dual Injectable and Topical Capability
Most hyaluronidase products are formulated exclusively for injection. The Innoaesthetics formulation supports both injectable and topical application protocols, giving practitioners additional flexibility in managing superficial HA deposits.
European Pharmaceutical Standards
Innoaesthetics is a Spanish aesthetics pharmaceutical specialist with a track record in producing professional-grade injectable products. Their manufacturing processes reflect European GMP standards important in a market where product purity and consistency directly affect patient safety outcomes.
Dosing Guide Hyaluronidase 500 IU in Clinical Practice
There is currently no universally standardised dosing protocol for hyaluronidase in aesthetic practice. The following guidance reflects the ranges used in clinical literature and expert consensus for the most common indications. Always adapt dosing to the specific filler type, volume, area, and clinical response.
|
Indication |
Typical Dose Range |
Notes |
|
Minor over-correction (lips, single area) |
75–150 IU |
Start conservatively; reassess at 2 weeks |
|
Moderate correction (cheeks, NLF) |
150–300 IU |
Adjust based on filler volume and type |
|
Tyndall effect |
75–150 IU |
Superficial placement — precision key |
|
Malar oedema / tear trough |
75–150 IU per session |
Conservative dosing; staged approach |
|
Vascular occlusion — emergency |
300–1500 IU+ (repeated doses) |
Use maximum available dose immediately; repeat every 60 min as needed |
|
Asymmetry correction |
75–200 IU (targeted side only) |
Precise placement to affected area only |
|
Topical application |
500 IU vial mixed with 2 ampoules saline |
Circular massage until absorbed |
STAGED CORRECTION PROTOCOL BEST PRACTICE
Session 1: Inject hyaluronidase conservatively into or adjacent to the filler deposit. Massage gently post-injection.
Wait 1 week: Allow full dissolution and tissue settling before reassessment.
Session 2 (if required): Reassess. Apply further hyaluronidase to any residual filler as needed.
Final assessment at 2 weeks: Review against pre-treatment photographs.
Application Protocol — Step by Step
Injectable Protocol
- Reconstitute the lyophilised product with 1ml of sterile saline solution immediately before usePhotograph the treatment area for pre/post comparison documentationAssess the filler deposit identify the specific area requiring correctionInject hyaluronidase directly into or adjacent to the HA filler deposit using a fine needle or blunt cannulaBegin with the minimum effective dose under-correction is easier to manage than over-dissolutionGently massage the treated area post-injection to help distribute the enzymeReassess the patient at a minimum of 2 weeks post-treatmentIf further correction is required, book a second session do not attempt full correction in a single aggressive session
Topical Protocol
- Mix the contents of one vial with two ampoules of sterile saline solutionApply the reconstituted solution to the treatment areaMassage in a circular motion until the solution is completely absorbed into the skinUse as directed by your clinical protocol and manufacturer guidance
⚠ Safety Requirements: Perform a sensitivity assessment where clinically indicated. Have anaphylaxis emergency protocols and equipment (including adrenaline) immediately available. Hyaluronidase activity diminishes within approximately 30 minutes in biological tissue in emergency scenarios, act immediately and repeat doses as required. Do not use in patients with known sensitivity to hyaluronidase, bee venom, or wasp venom. Reconstituted product must be used immediately do not store.
Safety Profile What the Evidence Shows
Hyaluronidase has been used in medicine for decades in anaesthetics, ophthalmology, oncology, and neonatal intensive care long before its adoption in aesthetic practice. The safety data accumulated across these applications is extensive, and the product's overall safety record is well-established.
Common Side Effects (Expected)
- Mild bruising at injection points — the most commonly reported side effect
- Temporary redness and swelling at the injection site
- Localised tenderness for 1–3 days
- Temporary reduction in tissue volume beyond the filler deposit (natural HA briefly affected)
Uncommon Side Effects
- Localised allergic reaction — urticaria, itching, or persistent redness at the injection site
- Insufficient dissolution requiring an additional session (particularly with monophasic fillers)
Rare but Serious
- Systemic hypersensitivity / anaphylaxis rare but possible; emergency protocols must be in place
- Post-hyaluronidase syndrome hollowing or volume loss beyond the filler area, particularly in patients with high cumulative filler volume over long periods
Post-Hyaluronidase Syndrome What Practitioners Should Know
Research by Wilde et al. (published in Plastic and Reconstructive Surgery Global Open) reviewing 90 patients found that approximately 18% experienced post-hyaluronidase syndrome facial hollowing or changes beyond the intended correction area. Critically, this was associated with the duration and total volume of filler the patient had accumulated over time, not the concentration or dose of hyaluronidase used. Patients with long-term or high-volume filler histories should be counselled about this risk before treatment.
Does Hyaluronidase Dissolve Natural HA? Does It Damage Collagen?
Two of the most frequently asked questions by practitioners and clients alike. The clinical answers are:
Natural HA: Yes hyaluronidase cannot distinguish between injected filler HA and the body's own naturally occurring HA. However, native dermal HA has a half-life of approximately 24 hours and is continuously replenished by the body. Any temporary effect on surrounding tissue HA resolves within days.
Collagen: No hyaluronidase is selective to hyaluronic acid. It does not break down collagen or elastin. Expert practitioners confirm that concerns about collagen damage are not clinically supported. In some cases, dissolving chronic or excessive filler can actually improve tissue health by relieving mechanical compression and improving lymphatic drainage.
Hyaluronidase 500 IU vs. Other Concentrations — Choosing the Right Dose Format
|
Concentration |
Common Use |
Limitations |
|
150 IU |
Lower-dose corrections, some topical protocols |
May be insufficient for emergency vascular occlusion; requires multiple vials for significant corrections |
|
500 IU (Innoaesthetics) |
Standard corrective and emergency use; staged protocols; topical application |
Well-suited for most indications; multiple vials available for high-dose emergencies |
|
1500 IU / 1500 IE |
High-volume dissolution; aggressive emergency protocols |
Less titratable for minor corrections; higher risk of over-dissolution in delicate areas |
The 500 IU concentration provides the right balance for most aesthetic practice needs. It is titratable enough for precise minor corrections while providing sufficient enzyme activity for more significant interventions. The 4-vial pack format means that emergency doses requiring 1500 IU or more can be achieved by combining multiple vials.
Note on European notation: "1500 IE" (Internationale Einheiten) is the German/European equivalent of "1500 IU" (International Units). The enzyme, mechanism, and clinical effect are identical — only the labelling convention differs by country.
Frequently Asked Questions
What is Innoaesthetics Hyaluronidase 4×500 IU used for?
Innoaesthetics Hyaluronidase is used by qualified aesthetic practitioners to dissolve hyaluronic acid (HA) fillers. Its primary indications are correcting over-correction, asymmetry, and Tyndall effect from HA filler treatments, managing vascular occlusion emergencies, treating lower eyelid oedema, improving hypertrophic scars, and managing skin fibrosis. It can also be used topically when mixed with saline solution.
How does hyaluronidase dissolve filler?
Hyaluronidase hydrolyses the molecular bonds within hyaluronic acid chains, breaking down the cross-linked HA gel matrix. When injected adjacent to or into a filler deposit, the enzyme degrades the filler's structure, reducing its viscosity and volumising properties. The broken-down HA fragments are then cleared by the body's lymphatic system — a process that begins within minutes and continues over hours to days.
How many units of hyaluronidase do I need to dissolve filler?
Dosing depends on the filler type, volume, area, and specific indication. Minor corrections in delicate areas (e.g. lips, tear trough) typically use 75–150 IU. Moderate corrections use 150–300 IU. Vascular occlusion emergencies require 300–1500 IU or more, administered repeatedly as needed. The 500 IU per vial format of Innoaesthetics allows precise, staged dosing across all these scenarios.
What is the difference between hyaluronidase 500 IU and 1500 IE?
These describe the same enzyme measured in the same unit of activity. "IU" (International Units) is the English abbreviation; "IE" (Internationale Einheiten) is the German/European equivalent. A product labelled 1500 IE contains exactly three times the enzyme activity of a 500 IU product. The mechanism and clinical effect are identical.
Does hyaluronidase work differently on biphasic and monophasic fillers?
Yes significantly. Biphasic fillers (with looser particle spacing) dissolve rapidly at lower hyaluronidase concentrations, often within 1–2 hours. Monophasic fillers (highly cross-linked) require higher concentrations, direct injection into the filler mass, and frequently multiple treatment sessions. Adjusting your dose and technique based on filler type is essential for predictable outcomes.
Does hyaluronidase damage collagen or permanently affect the face?
No hyaluronidase is selective to hyaluronic acid and does not break down collagen or elastin. It does temporarily affect naturally occurring HA in surrounding tissue, but native HA has a half-life of approximately 24 hours and is continuously replenished. The concern about permanent facial damage from hyaluronidase is not supported by clinical evidence when the treatment is performed by a qualified practitioner.
Heading
Post-hyaluronidase syndrome refers to adverse aesthetic outcomes primarily hollowing or volume loss beyond the intended correction area experienced by some patients after hyaluronidase treatment. Research indicates it is associated with the total cumulative volume of filler a patient has received over time, and the duration the filler has been in situ not the concentration or dose of hyaluronidase used. Patients with long histories of high-volume filler should be counselled about this risk before treatment.
How should hyaluronidase be stored?
Innoaesthetics Hyaluronidase is supplied in lyophilised (freeze-dried) format, which provides significantly greater stability than liquid preparations. Store as per manufacturer guidelines. Reconstitute with sterile saline immediately before use — the reconstituted product should not be stored. Do not keep reconstituted hyaluronidase in the syringe for use at a later time or date.
Can hyaluronidase be used topically?
Yes Innoaesthetics Hyaluronidase is formulated to support topical application. Mix the contents of one vial with two ampoules of saline solution and apply to the skin with circular massage until fully absorbed. This is useful for superficial HA deposits or as a complement to injectable correction in appropriate clinical scenarios.
Is hyaluronidase a prescription-only medicine in the UK?
In the UK, some hyaluronidase formulations are classified as prescription-only medicines (POM). Its use in aesthetic practice for dissolving cross-linked HA filler is considered an off-licence indication, and patients must be informed of this as part of the consent process. Practitioners should verify the regulatory status of their chosen product and ensure appropriate prescribing pathways are in place.
Related Products Every Filler Clinic Should Stock Alongside Hyaluronidase
- Sterile saline ampoules — for reconstitution of hyaluronidase
- Fine gauge needles (27G–30G) — for precise hyaluronidase injection
- Blunt-tip cannulas — for safer filler correction in high-risk areas
- Adrenaline (epinephrine) auto-injector — mandatory anaphylaxis emergency equipment
- Topical numbing cream (EMLA / LMX4) — for pre-treatment anaesthesia
- HA dermal fillers — for post-dissolution re-treatment as required
- Clinical photography equipment — essential for pre/post documentation
Order Innoaesthetics Hyaluronidase 4×500 IU
Available exclusively for qualified aesthetic practitioners. Freeze-dried for maximum stability. 4-vial pack for clinical readiness. Fast, reliable UK delivery from Gofillerss your trusted by aesthetic clinics nationwide.
Disclaimer: This article is intended for qualified aesthetic practitioners only. Hyaluronidase is a professional-grade product and is not for consumer purchase or use. Regulatory status varies by country — practitioners should verify local requirements before purchase. This content is for educational purposes and does not constitute medical advice. Always follow manufacturer guidelines for reconstitution, dosing, storage, and administration. Clinical references cited are provided for informational purposes; practitioners should consult the full published research and relevant clinical guidelines when developing their protocols. Medics World Supply is not liable for clinical outcomes resulting from product use.